Healthcare

Healthcare

Healthcare  Contact Us

Healthcare

There are many challenges facing healthcare, from aging populations, rapidly growing demand for health products and services, severe budget pressures and government reform to global health threats that defy conventional approaches. And each challenge requires the most imaginative of minds – people willing to ask big questions, take risks and tackle complex problems in new ways. At FleishmanHillard, we believe...

There are many challenges facing healthcare, from aging populations, rapidly growing demand for health products and services, severe budget pressures and government reform to global health threats that defy conventional approaches. And each challenge requires the most imaginative of minds – people willing to ask big questions, take risks and tackle complex problems in new ways. At FleishmanHillard, we believe there's an answer to every question that can be posed – we just have to be curious, persistent, collaborative and creative enough to find it. So regardless of the task – building brand loyalty, educating the public or defending a marketplace in the face of intense competition – our team provides the curiosity, experience and confidence to push the boundaries of healthcare communications.

What We Do

Reputation Management

Our teams provide a wide spectrum of reputation management consulting services, from support for leadership changes and mergers and acquisitions to employee communications, issues preparedness and crisis response. Equipped with proprietary tools such as our Authenticity Gap methodology, we help organizations across the healthcare sector identify and take positive steps toward managing the gaps between their brand and reputation.

Product Launch and Marketing

Each market and therapeutic category provides its own challenges, opportunities and circle of stakeholders. From clinical trial recruitment to end-of-lifecycle strategies, FleishmanHillard provides insights into the introduction and marketing of new and mature products. With a deep understanding of the regulatory environments and market complexities in which they work, our counselors have helped create powerful campaigns to launch products at a global, regional and national level – shaping a positive environment for product uptake and generating ongoing demand.

Clinical Trial Recruitment

FleishmanHillard provides specialized patient recruitment consulting for investigational pharmaceutical, biotechnology and medical device products. Working collaboratively with contract research organizations and our clients, we engage target populations through credible third-party sources – online and off – helping study sites raise awareness, educate and generate referrals.

Public Affairs and Government Relations

FleishmanHillard provides an in-depth understanding of local, regional and global healthcare issues, advocacy, alliance development, stakeholder engagement and government affairs. We help healthcare companies, trade associations and nongovernmental organizations navigate regulation, mobilize opinion leaders, and influence legislation and health policy. Our healthcare-focused public affairs experts around the world have extensive experience counseling organizations on the wide range of product, corporate and marketplace issues.

Digital and Social Outreach

FleishmanHillard’s digital and social experts worldwide help organizations apply new technologies, tools and channels to shape integrated communications programs that create a measurable impact. We work with clients to optimize the power of social media, including implementing policies for employees, launching branded promotional and unbranded educational campaigns, working with HR to enhance recruitment and retention, and coaching executives in the medium.

Verticals

Animal healthcare
Biotechnology
Health NGOs
Healthcare technology providers
Managed care and insurance providers
Medical equipment and device makers
Medical facilities and providers
Pharmaceuticals
Wholesalers

Resources

  • COVID-19 Mindset: The Safe Return to Healthcare Services ⁠— U.S. Elective Care Study

    Download COVID-19 Mindset: The Safe Return to Healthcare Services ⁠— U.S. Elective Care Study

  • Vulnerability and COVID-19: How Pandemic Times are Shaping the Views of Global HCPs, Patients and Caregivers

    Download Vulnerability and COVID-19: How Pandemic Times are Shaping the Views of Global HCPs, Patients and Caregivers

  • Pharmaceutical Drug Pricing: A Look at Reputation, New Players and the Media Landscape in the United States

    Download Pharmaceutical Drug Pricing: A Look at Reputation, New Players and the Media Landscape in the United States

Who We Are


Healthcare
  • Hidden Depths – The Impact of COVID-19 on the Pharmaceutical, Biotech and Devices Industries

    Mark Senak

    July 27, 2020

    Mark Senak The COVID-19 pandemic is shifting gears and with it, the ways in which we cope and respond. We are moving from an initial state of surprise, fear, consternation and a general lack of knowledge to an evolving understanding of consequences of the pandemic in our lives – that we are going to have to adapt...

  • Is It Too Risky to Visit Your Doctor?

    Anne de Schweinitz

    May 14, 2020

    Anne de Schweinitz The direct health impact of COVID-19 is flashed in front of us every day in the staggering numbers of infections, hospitalizations and deaths recorded around the globe. But the indirect impact of the pandemic due to the massive disruption in the healthcare delivery system – the cancelled surgeries, delayed appointments and undiagnosed illness – will...

  • Difficult Realities Related to Antibody Testing as a Tool in COVID-19 Recovery

    Mark Senak

    May 6, 2020

    Mark Senak In the 1980s as the AIDS epidemic took root in America, there was no test for Human Immunodeficiency Virus (HIV), the cause of Acquired Immune Deficiency Syndrome (AIDS). Rather, once developed, the HIV-antibody test was used as a surrogate marker to identify the infected. Particularly before there was a treatment, an antibody test became a...

  • Will COVID-19 Turn the Tide on Innovation for Pharma Companies?

    Emma Cracknell

    April 8, 2020

    Emma Cracknell The current COVID-19 pandemic has launched huge humanitarian waves across the globe, uniting the general public, healthcare providers, governments and industry around one common goal – to beat the virus. Even as countries begin easing the restrictive containment measures that govern our daily lives, we can be certain that the post-COVID-19 world will look radically...

  • J.P. Morgan Healthcare Conference: FDA Speaks

    Mark Senak

    January 9, 2019

    Mark Senak Yesterday Commissioner Scott Gottlieb was to take the podium to address attendees at the J.P. Morgan 36th Annual Healthcare Conference being held in San Francisco.  Unfortunately, due to the current government funding impasse, he did not make it. But had he been there, it is fair to say that he would have had a lot...

  • Gottlieb Signals Depth and Scope of Changes Coming to Drug and Device Approvals in FY 19 Budget Comments

    Mark Senak

    April 20, 2018

    Mark Senak On April 17, 2018, FDA Commissioner Scott Gottlieb appeared before the U.S. House Subcommittee on Agriculture, Rural Development to discuss the Fiscal Year 2019 budget request for FDA. He began by touting the broad achievement in record approvals last year for new molecular entities, generic drugs and medical devices. Faster approvals and a lower regulatory...

  • The Best of Cannes Lions Health: Smart Ideas, Well-Executed

    Heather Pierce

    June 20, 2016

    Heather Pierce The sheer volume of inspiring and excellent work shared at this year’s Cannes Lions Health has been remarkable—from breathtakingly beautiful films to stunning works of art and fantastically creative social campaigns. As I watched the awards ceremony presentations, I had two realizations. First, as health communicators we often get weighed down by our largely conservative...

  • Cannes Lions Health: Empathy Is the Key to Life-Changing Creativity

    Heather Pierce

    June 18, 2016

    Heather Pierce Earlier today at Cannes Lions Health, Genentech (a FleishmanHillard client) shared the powerful findings of their Lung Cancer Project, a study which sought to identify and understand unconscious bias. They found that an astonishing three out of four people had negative perceptions about lung cancer, which likely contributes to the high percentage of people diagnosed...

  • Is It Enough to Mean Well? The Importance of Empathy

    Heather Pierce

    March 3, 2016

    Heather Pierce A few weeks ago, I was helping to lead a client message training session for an amazing group of female philanthropists. These women are leading incredible global health initiatives, from addressing gender-based violence in Honduras and Trinidad to transforming sanitation in Vietnam and detecting and treating cervical cancer in India. As we were discussing their...

  • Can Technology Bridge the Gap Between Knowing and Doing?

    Heather Pierce

    October 14, 2015

    Heather Pierce Chronic disease prevention isn’t sexy. Its core tenets induce eye rolls with their basic simplicity: “Eat better. Exercise more.” Ugh, how boring. Isn’t there some pill I can take to stave off a heart attack or cancer? A one-time shot to make me diabetes-proof? Healthcare providers and public health professionals have long struggled with how...

  • The FleishmanHillard 2015 Social Health Survey

    Ephraim Cohen

    April 7, 2015

    Ephraim Cohen How people care for themselves and others using social and mobile media Which networks people use and how they use them differs greatly depending on age range as well as whether the person is looking for information about their own health or finding information as a caregiver to someone else. The charts below show the...

  • Putting Ebola Into Context

    Pippa Galbraith

    October 17, 2014

    Pippa Galbraith Striking a delicate balance between communicating a healthcare threat and managing public perceptions “Rumours and panic are spreading faster than the virus,” said Dr Margaret Chan, director general of the World Health Organisation on Monday this week. In the same speech she called the Ebola outbreak “a crisis for international peace and security”. While the...

  • No Roar From Pharma at Cannes Lions Health

    Jenyne Engelhardt

    June 15, 2014

    Jenyne Engelhardt And the Grand Prix winner is…Well, turns out we’re going to have to wait until next year at least in the pharmaceutical category. The pharma jury at the inaugural Cannes Lions Health festival shocked the audience at the Palais des Festivals by opting not to award one, throwing down a challenge to clients and agencies...

  • Saving Lives Is a Creative Endeavour

    Orla Burke

    June 15, 2014

    Orla Burke What if mobile phones could detect cancer cells? Or an ultrasound was performed via television? How would these disruptive technologies impact healthcare models and how would communications adapt to help save lives? These were amongst some of the most provocative questions asked on day one at Lions Health. During a session entitled Creative Ideas and Innovators...

  • Curiosity, Creativity and Healthcare

    Anne de Schweinitz

    June 12, 2014

    Anne de Schweinitz Some might think that those of us who work in healthcare lack the creative instinct, that our analytical minds and the rules restricting marketing and communications in the industry squeeze out any room for real originality and inspiration. I disagree completely. When I was a kid my favorite topic in school was biology. I was...

Most Recent

  • Hidden Depths – The Impact of COVID-19 on the Pharmaceutical, Biotech and Devices Industries

  • Is It Too Risky to Visit Your Doctor?

  • Difficult Realities Related to Antibody Testing as a Tool in COVID-19 Recovery

  • Will COVID-19 Turn the Tide on Innovation for Pharma Companies?

  • J.P. Morgan Healthcare Conference: FDA Speaks

By Author

By Date